News
Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, ...
The FDA approved Nubeqa for metastatic castration-sensitive prostate cancer based on significantly improved radiographic ...
COCOON dermatologic management lessened skin side effects and improved quality of life versus standard care for patients with ...
Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...
I’m here to prove that powerful phrase; after nearly 16 years living with incurable cancer, I know there’s more to my story ...
Zejula with Zytiga and prednisone delayed cancer growth and symptoms in patients with castration-sensitive prostate cancer ...
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results